bioRxiv · 10.1101/2021.10.05.463282
SARS-CoV-2 hijacks neutralizing dimeric IgA for enhanced nasal infection and injury
Abstract
Robust severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in nasal turbinate (NT) accounts for high viral transmissibility, yet whether neutralizing IgA antibodies can control it remains unknown. Here, we evaluated receptor binding domain (RBD)-specific monomeric B8-mIgA1 and B8-mIgA2, and dimeric B8-dIgA1 and B8-dIgA2 against intranasal SARS-CoV-2 challenge in Syrian hamsters. These antibodies exhibited comparably potent neutralization against authentic virus by competing with human angiotensin converting enzyme-2 (ACE2) receptor for RBD binding. While reducing viruses in lungs, pre-exposure intranasal B8-dIgA1 or B8-dIgA2 led to 81-fold more infectious viruses and severer damage in NT than placebo. Virus-bound B8-dIgA1 and B8-dIgA2 could engage CD209 as an alternative receptor for entry into ACE2-negative cells and allowed viral cell-to-cell transmission. Cryo-EM revealed B8 as a class II neutralizing antibody binding trimeric RBDs in 3-up or 2-up/1-down conformation. Therefore, RBD-specific neutralizing dIgA engages an unexpected action for enhanced SARS-CoV-2 nasal infection and injury in Syrian hamsters.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Zhou, B., Zhou, R., Chan, J. F.-W., Zeng, J., Zhang, Q., Yuan, S., Liu, L., Robinot, R., Shan, S., Ge, J., Kwong, H. Y.-H., Zhou, D., Xu, H., Chan, C. C.-S., Poon, V. K.-M., Chu, H., Yue, M., Kwan, K.-Y., Chan, C.-Y., Liu, N., Chan, C. C.-Y., Chik, K. K.-H., Du, Z., Au, K.-K., Huang, H., Man, H.-O., Cao, J., Li, C., Wang, Z., Zhou, J., Song, Y., Yeung, M.-L., To, K. K.-W., Ho, D. D., Chakrabarti, L. A., Wang, X., Zhang, L., Yuen, K.-Y., Chen, Z.. 2021-10-06. SARS-CoV-2 hijacks neutralizing dimeric IgA for enhanced nasal infection and injury. https://doi.org/10.1101/2021.10.05.463282
Cite the original work for its findings. Save a collection to share your selection of sources.